Chinese Medicinal Formula (MHGWT) for Relieving Diabetic Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
Table 1
Patient's assignment, values at screening, and safety values.
Variables
Group, number
value
MHGWT group ()
Placebo group ()
Screening values
Male, (%)
29 (51.79)
28 (50)
1.00
Female, (%)
27 (48.21)
28 (50)
1.00
Age (years)
60.71 ± 10.20
60.46 ± 10.60
0.90
Height (cm)
162.14 ± 7.04
162.11 ± 8.07
0.98
Weight (kg)
67.00 ± 12.44
66.49 ± 10.28
0.81
Body-mass index
25.41 ± 3.87
25.24 ± 3.08
0.80
Duration of diabetes (years)
10.59 ± 6.49
9.91 ± 6.68
0.59
Duration of DPN (years)
2.49 ± 1.86
9.91 ± 6.68
0.35
Baseline safety values
GPT (u/L)
25.82 ± 13.67
23.04 ± 8.24
0.20
Creatinine (mg/dL)
1.06 ± 0.25
1.06 ± 0.22
0.88
Fasting glucose (mmol/L)
155.84 ± 50.70
154.68 ± 47.82
0.90
HbA1c (%)
8.11 ± 1.71
7.86 ± 1.63
0.42
Triglycerides (mmol/L)
171.69 ± 195.91
200.76 ± 183.67
0.42
Total cholesterol (mmol/L)
189.65 ± 38.08
187.18 ± 49.22
0.77
Screening values and safety values were obtained at baseline. Data were presented as mean ± SD. values are calculated for the comparison of difference between MHGWT and placebo groups by independent -test and chi-square test. GPT: glutamic pyruvic transaminase. HbA1c: glycosylated hemoglobin.
